Vascepa (icosapent ethyl) is a prescription medication that is indicated for certain medical conditions. The sources you provided offer valuable information about the indications for Vascepa.

According to the drug label provided by the U.S. Food and Drug Administration (FDA), Vascepa is indicated as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe hypertriglyceridemia (TG levels of 500 mg/dL or higher) [3]. Hypertriglyceridemia is a condition characterized by high levels of triglycerides in the blood, which can increase the risk of cardiovascular disease.

The drug patent watch website also confirms that Vascepa is indicated for the treatment of severe hypertriglyceridemia [1]. It is important to note that Vascepa is not indicated as a standalone therapy for the management of high cholesterol levels (hypercholesterolemia).

Furthermore, the sources do not mention any additional indications for Vascepa beyond its use in severe hypertriglyceridemia. It is crucial to consult with a healthcare professional or refer to the prescribing information for a comprehensive understanding of the drug's indications, contraindications, and potential side effects.

In conclusion, Vascepa is indicated as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia [1][3].

Sources:
[1] Drug Patent Watch. Vascepa indications. Retrieved from https://www.drugpatentwatch.com/p/tradename/VASCEPA
[3] U.S. Food and Drug Administration. Vascepa prescribing information. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202057s035lbl.pdf